20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early ...
Mena FN

20/20 Biolabs Exclusively Licenses PSA Velocity Algorithm From The University Of South Carolina

Licensing Agreement Expands 20/20 BioLabs' AI-Enabled Multi-Cancer Early Detection Platform GAITHERSBURG, Md., May 12, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early ...